Andy Blackwell

Andy is ieso’s Chief Science & Strategy Officer. He steers the global science and technology strategy, ensuring it chimes with the commercial vision.

His varied scientific career splits into complementary thirds. In the first, within academia, at the universities of St Andrews and Cambridge, he focussed on how the brain works and how conditions occur. Next, as CSO of Cambridge Cognition, he explored drug-based therapeutics. Finally, as CSO here at ieso, he has investigated how the words exchanged between two people can best treat common mental health conditions. It is this unrivalled breadth of knowledge that makes him uniquely well placed to identify the breakthroughs that will defeat mental illness.

For the next chapter, his eye here at ieso is squarely fixed on digital therapy and the breakthroughs that data science is going to enable.

Andy’s aim has always been to help the largest volume of people. And the software-based digital therapeutics ieso is developing looks set to be even more scalable than the mental telehealth it was instrumental in pioneering.